Loading clinical trials...
Loading clinical trials...
The patients of Severe Alcoholic Hepatitis (SAH) will be included in study based on inclusion and exclusion criteria. The patients will be then randomized in 3 groups for therapy. They will receive ei...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Institute of Liver and Biliary Sciences, India
NCT04088370 · Alcoholic Hepatitis
NCT07060547 · Alcoholic Hepatitis, Alcohol-related Liver Disease
NCT06159244 · Severe Acute Alcoholic Hepatitis, Alcohol, and more
NCT06919458 · Alcoholic Hepatitis
NCT02344680 · Human Immunodeficiency Virus, HBV, and more
Institute of Liver and Biliary Sciences
New Delhi, National Capital Territory of Delhi
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions